Stock LABP LANDOS BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Landos Biopharma, Inc.

Equities

LABP

US5150692011

Real-time Estimate Cboe BZX
Other stock markets
 01:54:02 2024-05-20 pm EDT 		5-day change 1st Jan Change
22.37 USD -0.45% Intraday chart for Landos Biopharma, Inc. +0.92% +512.30%
May. 09 Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 North American Morning Briefing : Stocks Seen -2- DJ

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Downgrades Landos Biopharma to Neutral From Buy
MT
Jefferies Downgrades Landos Biopharma to Underperform From Hold, Cuts Price Target to $0.10 From $0.20
MT
SVB Securities Adjusts Landos Biopharma's Price Target to $3 from $16, Maintains Market Perform Rating
MT
Raymond James Downgrades Landos Biopharma to Market Perform From Outperform
MT
Jefferies Downgrades Landos Biopharma to Hold From Buy, Adjusts Price Target to $1.40 From $30
MT
Raymond James Adjusts Landos Biopharma's Price Target to $9 From $24, Keeps Outperform Rating
MT
JPMorgan Adjusts Price Target on Landos Biopharma to $7 From $15, Maintains Neutral Rating
MT
Craig-Hallum Adjusts Landos Biopharma's Price Target to $29.50 From $45, Reiterates Buy Rating
MT
Jones Trading Downgrades Landos Biopharma to Hold From Buy
MT
SVB Leerink Downgrades Landos Biopharma to Market Perform from Outperform, Adjusts Price Target to $16 from $20
MT
LANDOS BIOPHARMA : Craig-Hallum Starts Landos Biopharma at Buy with $45 Price Target
MT
LANDOS BIOPHARMA : HC Wainwright Starts Landos Biopharma at Buy With $50 Price Target
MT
LANDOS BIOPHARMA : Jones Trading Starts Landos Biopharma at Buy with $39 Price Target
MT
LANDOS BIOPHARMA : JPMorgan Starts Landos Biopharma at Neutral With $17 Price Target
MT
LANDOS BIOPHARMA : Jefferies Starts Landos Biopharma at Buy With $32 Price Target
MT
LANDOS BIOPHARMA : Raymond James Starts Landos Biopharma at Outperform With $33 Price Target
MT
LANDOS BIOPHARMA : SVB Leerink Starts Landos Biopharma at Outperform With $20 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LABP Stock
  4. News Landos Biopharma, Inc.
  5. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW